Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Influenza

Free Subscription 01.01.2020 1 Biochem Biophys Res Commun 1 Drug Saf 1 Epidemiol Infect 1 Eur J Epidemiol 1 J Gen Virol 1 J Infect 2 J Infect Dis 1 J Virol 1 MMWR Morb Mortal Wkly Rep 2 Pediatrics 1 PLoS Comput Biol 4 PLoS One 3 Proc Natl Acad Sci U S A 7 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Biochem Biophys Res Commun

1. CHEN F, Yang L, Huang Y, Chen Y, et al
   Isocorilagin, isolated from Canarium album (Lour.) Raeusch, as a potent neuraminidase inhibitor against influenza A virus.
   Biochem Biophys Res Commun. 2019 Dec 13. pii: S0006-291X(19)32363.
   PubMed     Text format     Abstract available
   
   

   
   Drug Saf

2. DOS SANTOS G, Nguyen BY, Damaso S, Godderis L, et al
   Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.
   Drug Saf. 2019 Dec 28. pii: 10.1007/s40264-019-00893.
   PubMed     Text format     Abstract available
   
   

   
   Epidemiol Infect

3. LIU W, Dai Q, Bao J, Shen W, et al
   Influenza activity prediction using meteorological factors in a warm temperate to subtropical transitional zone, Eastern China.
   Epidemiol Infect. 2019;147:e325.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Epidemiol

4. GHADERI S, Berg-Hansen P, Bakken IJ, Magnus P, et al
   Hospitalization following influenza infection and pandemic vaccination in multiple sclerosis patients: a nationwide population-based registry study from Norway.
   Eur J Epidemiol. 2019 Dec 23. pii: 10.1007/s10654-019-00595.
   PubMed     Text format     Abstract available
   
   

   
   J Gen Virol

5. TEPPER V, Nykvist M, Gillman A, Skog E, et al
   Influenza A/H4N2 mallard infection experiments further indicate zanamivir as less prone to induce environmental resistance development than oseltamivir.
   J Gen Virol. 2019 Dec 19. doi: 10.1099/jgv.0.001369.
   PubMed     Text format     Abstract available
   
   

   
   J Infect

6. CHARLTON M, Dunn C, Dashey S, Lai FY, et al
   Severe influenza a cases requiring extra-corporeal membrane oxygenation (ECMO) therapy, 2018-2019.
   J Infect. 2019 Dec 25. pii: S0163-4453(19)30381.
   PubMed     Text format    
   
   

   
   J Infect Dis

7. DAWOOD FS, Garg S, Fink RV, Russell ML, et al
   Epidemiology and clinical outcomes of hospitalizations for acute respiratory or febrile illness and laboratory-confirmed influenza among pregnant women during six influenza seasons, 2010-2016.
   J Infect Dis. 2019 Dec 26. pii: 5687022. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
8. SHI N, Huang J, Zhang X, Bao C, et al
   Corrigendum to: Interventions in Live Poultry Markets for the Control of Avian Influenza: A Systematic Review and Meta-analysis.
   J Infect Dis. 2019 Dec 20. pii: 5682401. doi: 10.1093.
   PubMed     Text format    
   
   

   
   J Virol

9. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
   N-Linked Glycans and K147 Residue on Hemagglutinin Synergize to Elicit Broadly-Reactive H1N1 Influenza Antibodies.
   J Virol. 2019 Dec 18. pii: JVI.01432-19. doi: 10.1128/JVI.01432.
   PubMed     Text format     Abstract available
   
   

   
   MMWR Morb Mortal Wkly Rep

10. HUGHES MM, Carmack AE, McCaffrey K, Spencer M, et al
    Estimating the Incidence of Influenza at the State Level - Utah, 2016-17 and 2017-18 Influenza Seasons.
    MMWR Morb Mortal Wkly Rep. 2019;68:1158-1161.
    PubMed     Text format     Abstract available
    
    

    
    Pediatrics

11. KRILOV LR
    Respiratory Syncytial Virus Immunoprophylaxis: Issues in Short-term and Longer-term Impact.
    Pediatrics. 2019;144.
    PubMed     Text format    
    
    
12. FINK AK, Graff G, Byington CL, Loeffler DR, et al
    Palivizumab and Long-term Outcomes in Cystic Fibrosis.
    Pediatrics. 2019;144.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Comput Biol

13. ENDO A, Uchida M, Kucharski AJ, Funk S, et al
    Fine-scale family structure shapes influenza transmission risk in households: Insights from primary schools in Matsumoto city, 2014/15.
    PLoS Comput Biol. 2019;15:e1007589.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

14. KASSEM E, Na'amnih W, Bdair-Amsha A, Zahalkah H, et al
    Comparisons between ethnic groups in hospitalizations for respiratory syncytial virus bronchiolitis in Israel.
    PLoS One. 2019;14:e0214197.
    PubMed     Text format     Abstract available
    
    
15. JAGANATH D, Wobudeya E, Sekadde MP, Nsangi B, et al
    Seasonality of childhood tuberculosis cases in Kampala, Uganda, 2010-2015.
    PLoS One. 2019;14:e0214555.
    PubMed     Text format     Abstract available
    
    
16. KOLOSOVA NP, Ilyicheva TN, Danilenko AV, Bulanovich JA, et al
    Correction: Severe cases of seasonal influenza in Russia in 2017-2018.
    PLoS One. 2019;14:e0227382.
    PubMed     Text format     Abstract available
    
    
17. ZHOU W, Xiao Y, Heffernan JM
    Optimal media reporting intensity on mitigating spread of an emerging infectious disease.
    PLoS One. 2019;14:e0213898.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

18. MCCARTHY KR, Raymond DD, Do KT, Schmidt AG, et al
    Affinity maturation in a human humoral response to influenza hemagglutinin.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1915620116.
    PubMed     Text format     Abstract available
    
    
19. VIRK RK, Jayakumar J, Mendenhall IH, Moorthy M, et al
    Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1916585116.
    PubMed     Text format     Abstract available
    
    
20. NICKBAKHSH S, Mair C, Matthews L, Reeve R, et al
    Virus-virus interactions impact the population dynamics of influenza and the common cold.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1911083116.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

21. LUTZ CS, Fink RV, Cloud AJ, Stevenson J, et al
    Factors associated with perceptions of influenza vaccine safety and effectiveness among adults, United States, 2017-2018.
    Vaccine. 2019 Dec 27. pii: S0264-410X(19)31644.
    PubMed     Text format     Abstract available
    
    
22. BERTRAN K, Criado MF, Lee DH, Killmaster L, et al
    Protection of White Leghorn chickens by recombinant fowlpox vector vaccine with an updated H5 insert against Mexican H5N2 avian influenza viruses.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31626.
    PubMed     Text format     Abstract available
    
    
23. RAO S, Ziniel SI, Khan I, Dempsey A, et al
    Be inFLUential: Evaluation of a multifaceted intervention to increase influenza vaccination rates among pediatric inpatients.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31652.
    PubMed     Text format     Abstract available
    
    
24. DE HOOG MLA, Venekamp RP, Meijer A, Sanders EAM, et al
    Inactivated influenza vaccine does not reduce all cause respiratory illness in children with pre-existing medical conditions.
    Vaccine. 2019 Dec 16. pii: S0264-410X(19)31640.
    PubMed     Text format     Abstract available
    
    
25. OFFEDDU V, Low MSF, Surendran S, Kembhavi G, et al
    Acceptance and feasibility of school-based seasonal influenza vaccination in Singapore: A qualitative study.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31662.
    PubMed     Text format     Abstract available
    
    
26. DHAMAYANTI M, Tarigan R, Fadlyana E, Prasetyo D, et al
    Immunogenicity and safety of Quadrivalent Influenza HA vaccine in Indonesian children: An open-labeled, bridging, clinical study.
    Vaccine. 2019 Dec 17. pii: S0264-410X(19)31650.
    PubMed     Text format     Abstract available
    
    
27. BEYER WEP, Palache AM, Reperant LA, Boulfich M, et al
    Association between vaccine adjuvant effect and pre-seasonal immunity. Systematic review and meta-analysis of randomised immunogenicity trials comparing squalene-adjuvanted and aqueous inactivated influenza vaccines.
    Vaccine. 2019 Dec 23. pii: S0264-410X(19)31679.
    PubMed     Text format     Abstract available
    
    

    
    Virology

28. LEE Y, Ko EJ, Kim KH, Lee YT, et al
    A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus.
    Virology. 2019;534:1-13.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: